Clinical Trial Update: Vinorelbine and Gemcitabine in Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vinorelbine and gemcitabine in patients with multiple myeloma (and amyloidosis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Multiple Myeloma

Drugs mentioned

• Gemzar (gemcitabine)
• Navelbine (vinorelbine)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Multiple Myeloma, Amyloidosis | Phase 2 | Status: COMPLETED